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PreviewsAlthough the current view is that TCR
internalization dampens signaling by re-
moving the antigen and promoting re-
ceptor degradation, internalization of a
pMHC-TCR complex by trogocytosis
opens new questions. Is internalization
by trogocytosis a way to prolong the
TCR-pMHC interaction even after APC
separation? Are those TCRs still signaling
competent? In this regard, RhoG- or
TC21-deficient T cells stimulated by
APCs showed increased upregulation of
early TCR-mediated activation markers,
such as CD69. This could suggest that
signaling of TCRs from the cell surface
is required to stimulate TC21- and
RhoG-independent signaling cascades
that upregulate CD69. In contrast, T cell
proliferation was reduced in RhoG- or
TC21-deficient T cells, either suggesting
that trogocytosed TCRs are required to
stimulate proliferation or that RhoG and
TC21 are involved in the signaling path-
ways that promote proliferation.
Taken together, these data open novel
possibilities to study the functional conse-
quences of trogocytosis. Lineage-specific
deletion of RhoG could be useful to study
the contribution of trogocytosis in differ-
ent cell types in the course of immuneresponses, helping to characterize the
stimulatory or suppressive effects that
have been attributed to trogocytosis. T
helper cells that have captured pMHC via
trogocytosis can present these pMHC
complexes to other T cells, amplifying an
immune response. Cytotoxic T cells (CTLs)
that have captured agonistic pMHC by tro-
gocytosis become susceptible to cytolysis
by neighboring CTLs, which could result
in a dampening of an immune response.
While trying to understand the purpose
and consequences of trogocytosis, ener-
getic concerns arise: how do T cells
generate the force needed to tear off
the APC-membrane patch containing
pMHC?The force required topull a protein
and surrounding lipids from a membrane
is on the same order of magnitude as
the force needed to break a high-affinity
protein-protein interaction (Bell, 1978).
Therefore, trogocytosis could be energet-
ically beneficial for the T cell, given that
the acquired lipids could be recycled or
metabolized. This might increase the
capacity of the T cell to proliferate.
In that sense, T cells that are blood cells
themselves and take up protein com-
plexes in membrane ‘‘bites’’ from other
cells could be fancied as little vampiresImmunity 35that feed from their victims without killing
them.
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CD8+ dendritic cells comprise a distinct cell type whose function is unclear. In this issue of Immunity,
Mashayekhi et al. (2011) show these cells are essential for protection against the parasite Toxoplasma, but
Edelson et al. (2011) show they are hijacked by Listeria during initial spreading.Dendritic cells (DCs) are a distinct lineage
of mononuclear phagocytes that excel
at pathogen sensing, cytokine secretion,
and antigen presentation. The classical
DCs comprise two distinct subsets, dis-
tinguished in themouse by the expression
of CD8a (Shortman and Heath, 2010).
This subset dichotomy exists not only inlymphoid organs but also in tissues, in
which CD103+ DCs represent a genetic
and functional equivalent of CD8+ DCs.
Notably, CD8+ and CD103+ DCs are
found in relatively low numbers in vivo
(0.1%–0.2% of murine splenocytes), to
the dismay of researchers who study
them. A DC subset similar to CD8+ DCshas been identified in humans, with this
conservation probably reflecting an es-
sential role in immunity. An overwhelming
body of evidence suggests that CD8+
DCs are particularly efficient at cross-pre-
sentation, i.e., the presentation of exoge-
nously acquired antigens on MHC class I
molecules to CD8+ T cells. Although this, August 26, 2011 ª2011 Elsevier Inc. 153
Figure 1. The Dual Role of CD8+ DCs in the Response to Intracellular Pathogens
Infection by intracellular protozoan Toxoplasma causes the expansion in numbers of CD8+ DCs and
production of IL-12 by these cells. DC-derived IL-12 induces the production of IFN-g by other immune
cell types such as T and NK cells and leads to productive inflammation and pathogen clearance. During
infection by intracellular bacteria Listeria, infected CD8+ DCs transport the pathogen to the splenic white
pulp, which enables Listeria replication and induces apoptosis of lymphocytes.
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Previewsproperty is important in certain settings
such as immune responses to tumors
and viruses, a broader role of CD8+ DCs
in immunity to infections remains poorly
understood.
As any good defense system, the im-
mune system has multiple layers of pro-
tection and redundancy, often frustrating
our attempts to define the roles of indi-
vidual cell types. Luckily, these attempts
have been aided by molecular insights
into the development of immune cell
lineages, including DC subsets. In 2008,
Murphy and colleagues identified the
transcription factor Batf3 as a specific
regulator of CD8+ DC development (Hild-
ner et al., 2008). Batf3 is expressed in
both CD8+ and CD8- DC subsets, yet the
deletion of Batf3 caused a specific loss
of CD8+ DCs. Although the molecular
mechanism of subset-specific Batf3 ac-
tivity remains to be characterized, Batf3-
deficient mice provide an elegant system
for addressing the function of CD8+ DCs
in vivo. As expected, these mice are defi-
cient in cross-presentation and tumor cell
rejection and show impaired priming of
virus-specific CD8+ T cells.154 Immunity 35, August 26, 2011 ª2011 ElsToxoplasma gondii is an intracellular
protozoan parasite that elicits strong
immune response involving both innate
and adaptive mechanisms. Interferon
gamma (IFN-g) secreted by T cells and
other cell types such as NK cells is
critical for Toxoplasma clearance, and
interleukin-12 (IL-12) is an essential
inducer of IFN-g production. Reis e
Sousa et al. (1997) first demonstrated
that DCs represent a primary source of
IL-12 in response to Toxoplasma infec-
tion. Indeed, DC depletion abrogated
IL-12 and IFNg production and made
mice highly susceptible to Toxoplasma
(Liu et al., 2006). More recently,
blockade of Toll-like receptor (TLR) and
interleukin-1 signaling in DCs but not in
macrophages or neutrophils was shown
to impair IL-12 production and increase
susceptibility to Toxoplasma (Hou et al.,
2011). These results collectively suggest
that DCs directly sense Toxoplasma
through TLRs and secrete IL-12 to
initiate the IFN-g-dominated protective
immunity. However, the precise DC
subset(s) responsible for IL-12 secretion
remained moot.evier Inc.In this issue of Immunity, Mashayekhi
et al. (2011) now demonstrate that Batf3-
deficient mice are highly susceptible to
Toxoplasma, show greatly diminished
IL-12 and IFN-g production, and fail to ex-
pand Toxoplasma-specific CD8+ T cells
(Figure 1). As in the study by Hou et al.,
IL-12 administration substantially rescued
these defects, suggesting that IL-12 pro-
duction rather than antigen presentation
by CD8+ DCs is essential for protection.
A clever reconstitution experiment gen-
erated chimeric mice in which CD8+
DCs were present but unable to produce
IL-12, and these chimeras showed the
same susceptibility to infection. These
data clearly establish IL-12 production
as a unique property of CD8+ DCs that is
essential for protective immune response
against Toxoplasma. In agreement with
this, the study describes massive expan-
sion of CD8+ DCs during the natural
course of infection—an intriguing phe-
nomenon that warrants future studies of
its mechanism.
Given the powerful IL-12 secretion
and cross-presentation capacity of CD8+
DCs, an intuitive assumption would be
that more of these cells would confer
more protection against any intracellular
pathogen. However, Wilson and col-
leagues reported back in 2004 that the
administration of DC growth factor Flt3L
increased sensitivity to obligate intracel-
lular bacterial pathogens such as Listeria
monocytogenes (Alaniz et al., 2004).
These authors proposed that DCs are
‘‘sentinels without armament’’ that cap-
ture and present bacteria but cannot
kill them; thus DC expansion increases
the cellular niche for bacterial replica-
tion. Notably, Flt3L preferentially expands
CD8+ DCs, implicating this subset as
a potential culprit. More recently, mice
with a specific expansion of CD8+ DC
compartment were similarly shown to be
highly susceptible to Listeria (Sathaliya-
wala et al., 2010). In both studies, in-
creased early replication of Listeria was
observed, whereas the subsequent CD8+
T cell response was normal or increased.
These observations suggest that CD8+
DCs may represent ‘‘Trojan horses’’ for
theentryand/orearly expansionofListeria,
albeit in artificial settings of cytokine ad-
ministration or genetic manipulation.
In parallel, an elegant study from the
Busch group (Neuenhahn et al., 2006)
showed that DC depletion abrogated
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PreviewsListeria infection by preventing its early
spread and proliferation in the spleen
(but not in the liver). Indeed, DCs were
shown by multiphoton microscopy to
rapidly deliver Listeria to the lympho-
cyte-rich splenic white pulp (Aoshi et al.,
2008), in which it replicates rapidly and
causes widespread apoptosis. Although
Neuenhahn et al. implicated CD8+ DC
subset in the initial capture and transport
of Listeria, a system to specifically de-
plete CD8+ DCs was not available at the
time. Now in the same issue of Immunity,
Edelson et al. (2011) used Batf3-deficient
animals to explicitly identify CD8+ DCs as
a key cell type for the entry and early
spread of Listeria (Edelson et al., 2011)
(Figure 1). Indeed, Batf3-deficient mice
are essentially resistant to Listeria, re-
quiring 100- to 1000-fold more bacteria
for equivalent bacterial replication. In the
absence of CD8+ DCs, bacteria failed to
spread to the white pulp and instead
were rapidly cleared by phagocytic cells.
By microscopy and flow cytometry, Edel-
son et al. (2011) detected occasional
CD8+ DCs that become infected with
Listeria and carry it to the white pulp, sug-
gesting that it is a rare but nevertheless
essential event for productive infection.
The study by Edelson et al. (2011)
provides important additional insights
into the role of CD8+DC subset in intracel-
lular bacterial infection. First, Batf3-defi-
cient mice were more resistant to Listeria
ivanovii, which replicates only in the liver
but not in the spleen. This result provides
strong genetic evidence that CD103+ DCs
in the liver play an equivalent role in the
transport and early replication of Listeria.
Second, the absence of CD8+ DCs did
not diminish protective T cell responseto Listeria, particularly when adjusted
for bacterial burden. Therefore, different
antigen-presenting cell type(s) such as
CD8- DCs or macrophages are fully cap-
able of priming a functional T cell re-
sponse to Listeria. This is perhaps not
surprising, given that the antigens of intra-
cellular Listeria may have access to the
canonical endogenous presentation path-
way and would not require cross-presen-
tation. Nevertheless, these results clearly
dissociate the obligatory (and detrimental)
role of CD8+ DCs in the capture and trans-
port of Listeria from their dispensable role
in T cell priming.
The studies by Mashayekhi et al. (2011)
and Edelson et al. (2011) are significant
in several ways. First, they provide clear
genetic evidence that DCs and their sub-
sets such as CD8+ DCs have specific
nonredundant functions in ‘‘real’’ immune
responses. Because immunologists tend
to endlessly subdivide any cell type by
using random surface markers, this is a
deeply satisfying reality check. Second,
they highlight the unique role of DCs in
pathogen sensing and initiation of im-
mune responses, as opposed to direct
pathogen killing mediated by other
myeloid cells. This is a clear asset in some
infections such as Toxoplasma, where
CD8+ DCs rapidly activate multiple cell
types to contain the pathogen; however,
clever pathogens such as Listeria can
exploit it to facilitate their own spread.
Finally, the identification of CD8+ DCs as
a liability in certain infections provides a
compelling reason for very low numbers
of these cells in vivo. Indeed, specific
cell-intrinsic mechanisms appear to re-
strict proliferative signals and control the
number of CD8+ DCs in the steady stateImmunity 35(Sathaliyawala et al., 2010). This caveat
should be taken into consideration in any
attempt to expand or reconstitute DCs for
therapeutic purposes, e.g., as anticancer
vaccines.
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